by Mammography is a technique used in breast imaging to detect or diagnose breast cancer early. Digital mammography systems make use of digital receptors and computers to capture and process breast images. Digitized images can be enhanced, shared electronically, and compared with previous images more easily as compared to conventional film mammography.
The global Mammography Market is estimated to be valued at US$ 2718.91 Mn in 2023 and is expected to exhibit a CAGR of 6.8% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
Digitalization: Digital mammography systems are increasingly replacing conventional film mammography systems due to advantages such as reduced radiation dose and immediate access to results. Digital mammography uses digital receptors instead of X-ray films to capture breast images. The digitized images can be enhanced, stored electronically, and easily shared over networks. This has simplified workflow processes and enabled remote diagnosis. Increased adoption of digital mammography systems is expected to drive the market growth over the forecast period.
SWOT Analysis
Strength: Mammography provides early breast cancer detection which significantly increases survival rates. Targeted screening and diagnostic programs help improve outcomes.
Weakness: High cost of equipment and maintenance limits widespread access. Screening coverage and awareness needs improving in developing regions.
Opportunity: Emerging nations to drive future growth as screening programs expand. Technological advances enabling improved specificity and reduced radiation exposure.
Threats: Competing modalities like MRI and ultrasound limiting exclusive use in breast imaging. Biosafety concerns around long-term radiation exposure need addressing.
Key Takeaways
The global Mammography market demand is expected to witness high growth. The global Mammography Market is estimated to be valued at US$ 2718.91 Mn in 2023 and is expected to exhibit a CAGR of 6.8% over the forecast period 2024 to 2031.
North America currently dominates the market due to supportive reimbursement policies and cancer screening awareness programs. Asia Pacific shows high potential with growing healthcare infrastructure and expanding diagnostic capabilities in major countries.
Key players
operating in the Mammography market are GTL (Global Tel*Link Corporation), BI Incorporated (a subsidiary of GEO Group), Corrisoft, SuperCom Ltd., Spillman Technologies (a Motorola Solutions company), Tribridge (now DXC Technology), Appriss Inc., Northpointe Inc. (a subsidiary of Constellation Software), Tyler Technologies Inc., Capita PLC, IBM Corporation, Encartele Inc., Telmate LLC (a subsidiary of GTL), Keefe Group (a subsidiary of TKC Holdings Inc.), Securus Technologies Inc. (now part of Aventiv Technologies). Technological innovations through R&D remain imperative for leaders to sustain their market presence. Collaborations for broadening clinical applications and geographic expansion strategies also impact the competitive dynamics.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
